Abstract
We have previously shown a conserved glutamate/dileucine motif (335 ELRSLL 340) in the intracellular C terminus of the vasopressin V2 receptor (V2 receptor) to be essential for receptor transport from the endoplasmic reticulum (ER) to the Golgi apparatus. The motif may represent a transport signal that is recognized by a component of ER to Golgi vesicles. Alternatively, it may be necessary for transport-competent receptor folding to pass the quality-control system of the ER. To assess these two possibilities, we constructed a receptor fragment that allows transport studies independent of full-length receptor folding. Transmembrane domains II–VII were deleted, thereby fusing the intracellular C terminus to the first cytoplasmic loop. The mutations that impaired transport of the full-length receptor were introduced, and receptor fragments were localized in transiently transfected HEK 293 cells. All mutant receptor fragments were detectable at the plasma membrane, demonstrating that the glutamate/dileucine motif does not function as a small, linear vesicular transport signal. Instead, our data strongly suggest that this motif is required for transport-competent folding of the full-length receptor. To assess the underlying conformational features, a three-dimensional homology model of the V2 receptor was computed. Our model predicts that the glutamate/dileucine motif contributes to a U-like loop within the intracellular C terminus. Residue Leu339 may be required for folding back the intracellular C terminus to residue Leu62 of the first cytoplasmic loop. We characterized the naturally occurring L62P and ΔL62-R64 mutations in the first cytoplasmic loop and show that they lead to transport-defective full-length V2 receptors that are retained in the ER, consistent with the structure model.
Footnotes
-
Send reprint requests to: Ralf Schülein, Forschungsinstitut für Molekulare Pharmakologie (FMP), Alfred-Kowalke-Str. 4, D-10315 Berlin, Germany. E-mail:schuelein{at}fmp-berlin.de
-
↵1 G.K. and R.H. contributed equally to this work.
-
This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 449). R.H. is the recipient of a fellowship from the Deutscher Akademischer Austauschdienst (DAAD).
- Abbreviations:
- GPCR
- G protein-coupled receptor
- AVP
- arginine vasopressin
- ER
- endoplasmic reticulum
- EndoH
- endoglycosidase H
- GFP
- green fluorescent protein
- ICL
- intracellular loop
- PAGE
- polyacrylamide gel electrophoresis
- PhoA
- Escherichia coli alkaline phosphatase
- PNGaseF
- peptideN-glycosidase F
- TM
- transmembrane domain
- Received April 13, 1999.
- Accepted October 13, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|